Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Tuesday.
Other equities analysts have also issued reports about the company. Oppenheimer lowered Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. B. Riley started coverage on Tactile Systems Technology in a report on Thursday, September 26th. They set a “buy” rating and a $23.00 price objective for the company. Finally, BTIG Research cut Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 5th.
View Our Latest Report on TCMD
Tactile Systems Technology Trading Down 0.6 %
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. Arcadia Investment Management Corp MI purchased a new stake in Tactile Systems Technology in the third quarter valued at approximately $29,000. Gladius Capital Management LP bought a new stake in shares of Tactile Systems Technology in the 3rd quarter worth approximately $44,000. Quarry LP bought a new position in shares of Tactile Systems Technology during the 2nd quarter valued at $46,000. Magnetar Financial LLC purchased a new stake in Tactile Systems Technology during the second quarter valued at about $130,000. Finally, SG Americas Securities LLC purchased a new position in shares of Tactile Systems Technology in the third quarter worth about $156,000. 83.43% of the stock is currently owned by hedge funds and other institutional investors.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
See Also
- Five stocks we like better than Tactile Systems Technology
- How to Invest in Blue Chip Stocks
- Work and Play: Investing in the Rise of Bleisure Travel
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Dividend Capture Strategy: What You Need to Know
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.